PharmaBoardroom

The executive managing director of a leading American healthcare provider offering an innovative range of products on the local Algerian market…

The genomic revolution represents a before and after in the field of medicine. Sistemas Genómicos has understood this back in 1998 and today is the…

The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new…

Biograft is the first private tissue bank in Mexico meeting the increasing demand for implants of human musculoskeletal tissue. The general director…

The general manager in charge of Mexico, Central America and the Caribbean is on board with the corporate mission of doubling Shire’s product sales…

Probiomed wants to move to the next level. The recently appointed general director discusses her plans to grow the business and expand…

Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the…

The CEO of Venter Pharma explains the challenges of bringing a diagnostic drug to the market, and how they hope to leverage the science behind their…

Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

The founder of this spin-off of the Autonomous University of the State of Morelos focusing on biologicals for human and veterinary use offers an…